2.660USD-5.34%Mkt Cap: 87.37M USDP/E: 0.81Last update: 2026-06-01
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule fo…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap87.37M USD
Enterprise Value77.76M USD
Revenue (TTM)63.26M USD
Gross Profit42.34M USD
Net Income (TTM)6.82M USD
Revenue/Share2.267 USD
Last Price2.660 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees78
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.81
P/E (Forward)-1.59
PEG—
EV/EBITDA-1.19
EV/Revenue1.23
P/S1.47
P/B1.76
EPS (TTM)3.23
EPS (Forward)-1.76
52W Range
1.70034% of range4.530
52W High4.530 USD
52W Low1.700 USD
Profitability
Gross Margin66.92%
Oper. Margin-29.78%
EBITDA Margin-103.63%
Profit Margin10.77%
ROE13.66%
ROA3.67%
Growth
Revenue Growth6.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-65.78M USD
CapEx (TTM)—
FCF Margin-74.75%
FCF Yield-54.12%
Net Debt-12.16M USD
Net Debt/EBITDA0.19
Balance Sheet
Debt/Equity1.49
Current Ratio2.49
Quick Ratio2.20
Book Value/Sh1.590 USD
Cash/Share2.465 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateOct 10, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)11.00 USD
Target Range5.000 USD – 17.00 USD
# Analysts2
Ownership
Shares Out.33.22M
Float22.38M
Insiders22.79%
Institutions18.16%
Short Interest
Short Ratio10.4d
Short % Float18.13%
Short % Out.14.00%
Shares Short4.65M
Short (prev mo.)4.36M
Technical
SMA 502.521 (+5.5%)
SMA 2002.965 (-10.3%)
Beta1.16
S&P 52W Chg27.94%
Avg Vol (30d)341.36K
Avg Vol (10d)502.48K
Technical Indicators
RSI (14)64.2
MACD0.0888
MACD Signal0.0330
MACD Hist.+0.0558
BB Upper2.918 USD
BB Middle2.511 USD
BB Lower2.105 USD
BB Width32.38%
ATR (14)0.1421 USD
Vol Ratio (20d)0.73x